American Medical Systems delay for sterilisation tech trial
This article was originally published in Clinica
Executive Summary
American Medical Systems (AMS) has suspended temporarily a US clinical trial of its transcervical Ovion technology for permanently sterilising women, the company said in a July 12 SEC filing.